logo
welcome
Reuters

Reuters

US FDA approves Ionis Pharma's genetic disorder drug

Reuters
Summary
Nutrition label

79% Informative

U.S. Food and Drug Administration approves Ionis Pharmaceuticals' drug to treat a rare genetic disorder.

The drug, chemically known as olezarsen, is also the first approved treatment for familial chylomicronemia syndrome.

FCS is caused by the deficiency or impaired function of the lipoprotein lipase enzyme, responsible for breaking down triglycerides.

VR Score

87

Informative language

92

Neutral language

69

Article tone

formal

Language

English

Language complexity

62

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links